Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 4;11(11):1691.
doi: 10.3390/vaccines11111691.

Respiratory Syncytial Virus: Willingness towards a Future Vaccine among Pregnant Women in Italy

Grazia Miraglia Del Giudice  1 , Vincenza Sansone  1 , Francesca Airoma  1 , Silvia Angelillo  2 , Francesca Licata  2 , Gabriella Di Giuseppe  1
Affiliations

Respiratory Syncytial Virus: Willingness towards a Future Vaccine among Pregnant Women in Italy

Grazia Miraglia Del Giudice et al. Vaccines (Basel). .

Abstract

Background: This cross-sectional survey was designed to evaluate pregnant women's awareness regarding Respiratory Syncytial Virus (RSV) infection and willingness to receive the vaccine during pregnancy and to vaccinate their newborn against RSV.

Methods: An anonymous survey was administered from 20 April to 30 June 2023, to pregnant women aged ≥ 18 years attending gynecology wards of randomly selected public hospitals in southern Italy. A minimum sample size of 427 participants was calculated. The survey assessed women's socio-demographic characteristics, health-related information, their source(s) of information, and attitudes regarding RSV.

Results: A total of 490 women participated. Those who were married/cohabiting, with a high-school degree compared to those who had a university degree, and those who needed additional information were more concerned that the newborn could acquire the RSV infection. The perceived utility of a future RSV vaccine administered during pregnancy was higher among those who were married/cohabiting, with a university degree, those with very good perceived health status, those who received information from healthcare workers, and those who needed additional information. Only 45.9% were willing to be vaccinated during pregnancy, and this was more likely among those with a university degree, with a very good perceived health status, who had received information from healthcare workers, and who needed more information. Finally, almost two-thirds (61.1%) were willing to vaccinate their newborn, and this was more likely among women with a university degree, with a very good perceived health status, and who needed additional information.

Conclusions: An education campaign regarding RSV infection and its vaccine is needed in order to improve women's perception and to support healthcare workers in promoting it when it will be available.

Keywords: Italy; RSV; cross-sectional study; pregnancy; vaccine; willingness.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Zhang S., Akmar L.Z., Bailey F., Rath B.A., Alchikh M., Schweiger B., Lucero M.G., Nillos L.T., Kyaw M.H., Kieffer A., et al. Cost of respiratory syncytial virus-associated acute lower respiratory infection management in young children at the regional and global level: A systematic review and meta-analysis. J. Infect. Dis. 2020;222:S680–S687. doi: 10.1093/infdis/jiz683. - DOI - PubMed
    1. Baraldi E., Lanari M., Manzoni P., Rossi G.A., Vandini S., Rimini A., Romagnoli C., Colonna P., Biondi A., Biban P., et al. Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants. Ital. J. Pediatr. 2014;40:65. doi: 10.1186/1824-7288-40-65. - DOI - PMC - PubMed
    1. Li Y., Wang X., Blau D.M., Caballero M.T., Feikin D.R., Gill C.J., Madhi S.A., Omer S.B., Simões E.A.F., Campbell H., et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: A systematic analysis. Lancet. 2022;399:2047–2064. doi: 10.1016/S0140-6736(22)00478-0. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention Respiratory Syncytial Virus Infection (RSV)—Infants and Young Children. [(accessed on 29 September 2023)]; Available online: https://www.cdc.gov/rsv/high-risk/infants-young-children.html.
    1. Goddard N.L., Cooke M.C., Gupta R.K., Nguyen-Van-Tam J.S. Timing of monoclonal antibody for seasonal RSV prophylaxis in the United Kingdom. Epidemiol. Infect. 2007;135:159–162. doi: 10.1017/S0950268806006601. - DOI - PMC - PubMed

LinkOut - more resources